Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3827 ARTÍCULOS , VIENDO DEL 1201 AL 1215

Mitral valve injury after radiofrequency ablation for Wolff-Parkinson-White syndrome

Penaranda Canal JG, Enriquez-Sarano M, Asirvatham SJ, Munger TM, Friedman PA, Suri RM.

Circulation. 2013 Jun 25;127(25):2551-2. doi: 10.1161/CIRCULATIONAHA.113.002711.

Depression in Parkinson's disease: identification and management

Chen JJ, Marsh L.

Pharmacotherapy. 2013 Sep;33(9):972-83. doi: 10.1002/phar.1314. Epub 2013 Jun 24.

Neuronopathic lysosomal storage diseases: clinical and pathologic findings

Prada CE, Grabowski GA.

Dev Disabil Res Rev. 2013;17(3):226-46. doi: 10.1002/ddrr.1116.

Lentiform fork sign and fluctuating, reversible parkinsonism in a patient with uremic encephalopathy

Fabiani G, Teive HA, Munhoz RP.

Mov Disord. 2013 Jul;28(8):1053. doi: 10.1002/mds.25503. Epub 2013 Jun 24.

The role of vitamin D in pathophysiology and treatment of fibromyalgia

Jesus CA, Feder D, Peres MF.

Curr Pain Headache Rep. 2013 Aug;17(8):355. doi: 10.1007/s11916-013-0355-6.

Transdermal rotigotine in early stage Parkinson's disease: a randomized, double-blind, placebo-controlled trial

Mizuno Y, Nomoto M, Kondo T, Hasegawa K, Murata M, Takeuchi M, Ikeda J, Tomida T, Hattori N; Rotigotine Trial Group.

Mov Disord. 2013 Sep;28(10):1447-50. doi: 10.1002/mds.25537. Epub 2013 Jun 25.

Relation of lead trajectory and electrode position to neuropsychological outcomes of subthalamic neurostimulation in Parkinson's disease: results from a randomized trial

Witt K, Granert O, Daniels C, Volkmann J, Falk D, van Eimeren T, Deuschl G.

Brain. 2013 Jul;136(Pt 7):2109-19. doi: 10.1093/brain/awt151.

5-(6-(5-[(11)C]methylhexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl)pyridazin-3-yl)-1H-indole

Chopra A.

2013 Apr 9 [updated 2013 Jun 27]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013.

Clinical utility of DaTscan™ (123I-Ioflupane Injection) in the diagnosis of Parkinsonian Syndromes

Roussakis AA, Piccini P, Politis M.

Degener Neurol Neuromuscul Dis. 2013 Jun 27;3:33-39. doi: 10.2147/DNND.S19807. eCollection 2013.

The influence of skeletal muscle on systemic aging and lifespan

Demontis F, Piccirillo R, Goldberg AL, Perrimon N.

Aging Cell. 2013 Dec;12(6):943-9. doi: 10.1111/acel.12126. Epub 2013 Jul 17.

The Sac1 domain of SYNJ1 identified mutated in a family with early-onset progressive Parkinsonism with generalized seizures

Krebs CE, Karkheiran S, Powell JC, Cao M, Makarov V, Darvish H, Di Paolo G, Walker RH, Shahidi GA, Buxbaum JD, De Camilli P, Yue Z, Paisán-Ruiz C.

Hum Mutat. 2013 Sep;34(9):1200-7. doi: 10.1002/humu.22372. Epub 2013 Jul 19.

The substitute brain and the potential of the gel model

Pomfret R, Miranpuri G, Sillay K.

Ann Neurosci. 2013 Jul;20(3):118-22. doi: 10.5214/ans.0972.7531.200309.

Rankin scale as a potential measure of global disability in early Parkinson's disease

Simuni T, Luo ST, Chou KL, Fernandez H, He B, Parashos S.

J Clin Neurosci. 2013 Sep;20(9):1200-3. doi: 10.1016/j.jocn.2012.10.030. Epub 2013 Jun 26.

The serotonergic system in motor and non-motor manifestations of Parkinson's disease

Huot P, Fox SH.

Exp Brain Res. 2013 Oct;230(4):463-76. doi: 10.1007/s00221-013-3621-2. Epub 2013 Jun 28.

Atypical parkinsonism: an update

Stamelou M, Hoeglinger GU.

Curr Opin Neurol. 2013 Aug;26(4):401-5. doi: 10.1097/WCO.0b013e3283632da6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias